F. W. Bouwmeester, A. C. Bolte and H. P. van Geijn Pages 759 - 773 ( 15 )
Early postpartum hemorrhage remains a significant cause of maternal morbidity and mortality. Postpartum hemorrhage is most commonly due to uterine atony and often responds to medical treatments such as administration of uterotonic drugs, alone or in combination with uterine massage or bimanual compression. As the incidence of cesarean section continues to rise, the problem of placenta previa and accreta is likely to become more common. For first-line management of postpartum hemorrhage adequate blood and fluid replacement is mandatory. In recent years new therapeutic measures to control the bleeding have gained attention. Although, these newer therapies focus on avoiding the need for emergency hysterectomy and preservation of reproductive function, reports of subsequent pregnancies are still scarce. Established management options are shortly reviewed and novel medical and surgical treatments are more extensively discussed.
postpartum hemorrhage, atony, recombinant activated factor VII, tranexamic acid
Vrije Universiteit medical center, Department of Obstetrics and Gynecology, De Boelelaan 1117,1081HV Amsterdam, POBox 7057, 1007MB Amsterdam.